These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 9893262)

  • 1. Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
    Engel ME; Datta PK; Moses HL
    J Cell Biochem Suppl; 1998; 30-31():111-22. PubMed ID: 9893262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction by transforming growth factor-β: A cooperative paradigm with extensive negative regulation.
    Engel ME; Datta PK; Moses HL
    J Cell Biochem; 1998; 72 Suppl 30-31(S30-31):111-122. PubMed ID: 29345828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crossing Smads.
    Wrana JL
    Sci STKE; 2000 Mar; 2000(23):re1. PubMed ID: 11752591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Signaling pathways of transforming growth factor beta family members].
    Zimowska M
    Postepy Biochem; 2006; 52(4):360-6. PubMed ID: 17536504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of transforming growth factor-beta signaling.
    Zhu HJ; Burgess AW
    Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
    Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
    Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta receptors, in a Smad-independent manner, are required for terminal skeletal muscle differentiation.
    Droguett R; Cabello-Verrugio C; Santander C; Brandan E
    Exp Cell Res; 2010 Sep; 316(15):2487-503. PubMed ID: 20471380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse embryonic stem cells with aberrant transforming growth factor beta signalling exhibit impaired differentiation in vitro and in vivo.
    Goumans MJ; Ward-van Oostwaard D; Wianny F; Savatier P; Zwijsen A; Mummery C
    Differentiation; 1998 Jul; 63(3):101-13. PubMed ID: 9697304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fermentable metabolite of Zymomonas mobilis controls collagen reduction in photoaging skin by improving TGF-beta/Smad signaling suppression.
    Tanaka H; Yamaba H; Kosugi N; Mizutani H; Nakata S
    Arch Dermatol Res; 2008 Apr; 300 Suppl 1():S57-64. PubMed ID: 18060420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta family signal transduction in Drosophila development: from Mad to Smads.
    Raftery LA; Sutherland DJ
    Dev Biol; 1999 Jun; 210(2):251-68. PubMed ID: 10357889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New regulatory mechanisms of TGF-beta receptor function.
    Kang JS; Liu C; Derynck R
    Trends Cell Biol; 2009 Aug; 19(8):385-94. PubMed ID: 19648010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta signaling in cancer.
    Rich J; Borton A; Wang X
    Microsc Res Tech; 2001 Feb; 52(4):363-73. PubMed ID: 11170295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
    Franzén P; Heldin CH; Miyazono K
    Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II.
    Letourneur O; Goetschy JF; Horisberger M; Grütter MG
    Biochem Biophys Res Commun; 1996 Jul; 224(3):709-16. PubMed ID: 8713111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
    Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta signaling, Smads, and tumor suppressors.
    Padgett RW; Das P; Krishna S
    Bioessays; 1998 May; 20(5):382-90. PubMed ID: 9670811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.